Tennessee Oncology 250 20th Ave North — Nashville, Tennessee

Tennessee Oncology 250 20th Ave North is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Oncology 250 20th Ave North has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

• Vanderbilt University Medical Center Diagnostic Lab- Site Number : 840049
• 10-20 Vanderbilt University Medical Center
• Monroe Carell Jr Children's Hospital at Vanderbilt
• Vanderbilt University Medical Center Clinical Research Center
• Vanderbilt University Medical Center /ID# 204231
• Vanderbilt University Medical Center-GCRC
• GI Clinical Research; Vanderbilt University Medical Center
• Vanderbilt University Medical Center /ID# 164607
• The Children's Hospital at TriStar Centennial Medical Center
• Vanderbilt University Medical Center; Multiple Sclerosis Center
• Monroe Carrell Jr Children's Hospital at Vanderbilt
• Vanderbilt University ASAP Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology 250 20th Ave North?

Tennessee Oncology 250 20th Ave North has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology 250 20th Ave North conducted?

Tennessee Oncology 250 20th Ave North has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Tennessee Oncology 250 20th Ave North accredited by Crixeo Clinical Trials?

Tennessee Oncology 250 20th Ave North has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology 250 20th Ave North?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.